Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | +50.00% | 0.00% | +200.00% |
06/06 | Universal Ibogaine Inc. cancelled the transaction announced on April 22, 2024 | CI |
06/06 | Universal Ibogaine Inc. announced that it has received CAD 0.27 million in funding | CI |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Addiction Treatment Clinics and Ibogaine
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -3.81% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -3.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 10/22/10 |
Greg J. Leavens
DFI | Director of Finance/CFO | 59 | - |
Chief Operating Officer | - | - | |
Dugan Selkirk
IRC | Investor Relations Contact | - | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 10/22/10 |
James Duncan
BRD | Director/Board Member | - | 01/23/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 233,512,849 | 231,177,720 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Universal Ibogaine, Inc.
815 8th Avenue South West Suite 600
T2P 3P2, Calgary
+855-426-4246
http://www.universalibogaine.comSector
1st Jan change | Capi. | |
---|---|---|
+200.00% | 33.38L | |
+23.87% | 8.82TCr | |
-22.29% | 7.65TCr | |
+1.76% | 2.7TCr | |
+7.94% | 1.86TCr | |
-12.77% | 1.67TCr | |
+3.45% | 1.58TCr | |
+75.93% | 1.34TCr | |
+76.70% | 1.32TCr | |
+23.43% | 1.27TCr |
- Stock Market
- Equities
- IBO Stock
- Company Universal Ibogaine Inc.